GT Biopharma (GTBP) had the best year between 2012 and 2019 by a US stock in 2012, returning 3,044,698,370%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2012 | 3,044,698,370% |
PCB Bancorp (PCB) | 2014 | 527,363,000% |
TNF Pharmaceuticals (TNFA) | 2017 | 8,124,531.58% |
Weatherford International (WFRD) | 2019 | 6,855,450% |
DarioHealth (DRIO) | 2016 | 6,499,900% |
KULR Technology (KULR) | 2018 | 5,199,900% |
Alarum Technologies (ALAR) | 2018 | 4,829,168.29% |
Amerant Bancorp (AMTB) | 2018 | 4,080,166.67% |
Avalon GloboCare (ALBT) | 2018 | 2,578,025% |
QXO (QXO) | 2012 | 1,151,950% |
Inventrust Properties (IVT) | 2014 | 1,067,615% |
Nutex Health (NUTX) | 2013 | 749,900.2% |
GeoVax Labs (GOVX) | 2019 | 686,922.9% |
Delcath Systems (DCTH) | 2018 | 381,222.96% |
ABOT (ABOT) | 2017 | 259,063.49% |
Immatics (IMTX) | 2018 | 195,900% |
Freedom (FRHC) | 2017 | 115,536.36% |
Blackboxstocks (BLBX) | 2016 | 91,603.06% |
PetVivo (PETV) | 2014 | 64,689.33% |
AquaBounty Technologies (AQB) | 2017 | 48,788.89% |
LM Funding America (LMFA) | 2015 | 29,866.29% |
GT Biopharma (GTBP) | 2015 | 9,042.86% |
FingerMotion (FNGR) | 2017 | 8,400% |
Intellinetics (INLX) | 2012 | 8,066.67% |
Eastside Distilling (BLNE) | 2015 | 7,995.95% |
